Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangqin is the dried root of *Scutellaria baicalensis* Georgi, a cornerstone herb in Traditional Chinese Medicine (TCM) traditionally used to clear heat and dry dampness. In modern clinical research, it is investigated for its potent anti-inflammatory, antioxidant, and antifibrotic properties. The herb contains bioactive flavonoids, most notably baicalin, baicalein, and wogonin, which modulate key signaling pathways involved in tissue remodeling and inflammation, such as the TGF-beta/Smad and NF-kappaB pathways. It is currently being studied by the Hospital of Chengdu University of Traditional Chinese Medicine as a component of a herbal formula for the treatment of progressive pulmonary fibrosis (PPF), specifically targeting the phlegm heat-blood stasis pattern of the disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huangqin.